Biotage AB (Biotage AB) Interest Expense : $-5.5 Mil (TTM As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Biotage AB Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Biotage AB's interest expense for the three months ended in Mar. 2024 was $ -2.4 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-5.5 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Biotage AB's Operating Income for the three months ended in Mar. 2024 was $ 6.4 Mil. Biotage AB's Interest Expense for the three months ended in Mar. 2024 was $ -2.4 Mil. Biotage AB's Interest Coverage for the quarter that ended in Mar. 2024 was 2.68. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Biotage AB Interest Expense Historical Data

The historical data trend for Biotage AB's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotage AB Interest Expense Chart

Biotage AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.30

-0.36

-0.33

-0.48

-1.27

Biotage AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-	-0.84	-1.71	-0.59	-2.40

Biotage AB Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.5 Mil.

Biotage AB (OTCPK:BITGF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Biotage AB's Interest Expense for the three months ended in Mar. 2024 was $-2.4 Mil. Its Operating Income for the three months ended in Mar. 2024 was $6.4 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $35.3 Mil.

Biotage AB's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	6.435	/	-2.401
	=	2.68

The higher the ratio, the stronger the company's financial strength is.

Biotage AB (Biotage AB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (OTCPK:BITGF) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

BIOT:Sweden 0GRP:UK PQX1:Germany

Address

Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03

Website

https://www.biotage.com

Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.